http://sites.google.com/site/brconsultraining/

BR Consulting

 

 

provided by

 

 Raphy Bar, Ph.D. 

 

 

 

Raphael Bar is a pharmaceutical consultant for the Pharma and bio-Pharma industries. He is consulting various companies and provides development and analytical support to:

*  investigational drugs,

* generic drugs,

* new drugs and

* combination device-drug products

 

R. Bar is a member of the organizing committee of Israel Analytical Chemistry Society since 1996 and president of Israel Chapter of the Parenteral Drug Association (PDA) since Jan. 2007. He is presently also a member of the Scientific Advisory Board of global PDA.

 

With a doctorate in Chemistry (1984), Dr. Raphy Bar joined (1995) Teva Pharmaceuticals (Israel) and was the  head of the Analytical R&D Laboratory for three years. He was involved in preparation of ANDA files. He then joined Pharmos where he managed the quality control and R&D laboratory till 2007. As Senior Director of Analytical Development. he was actively involved in preparation of  CMC packages for several Phase 1, several Phase 2 and one Phase 3 clinical  trial studies.

 

Dr. Raphy Bar provides consulting services in pharmaceutical and analytical support and CMC project management of investigational, new, and generic drugs as well as medical devices and combination products. He also provides training in the fields of method development and validation as well as of statistical evaluation of laboratory and stability data.

 

Dr. Bar has been teaching courses to QC and R&D personnel from pharmaceutical laboratories for more than ten years both internationally and in Israel.

 

Dr. Bar has authored over 40 peer-reviewed papers, of which the last two papers address statistical analysis of drug stability data.